“BLOOD-BASED BIOMARKERS FOR PREDICTING POST-STROKE PROGNOSIS: A SCOPING REVIEW OF PENTRAXIN-3, NEUROPENTRAXIN-1, AND NEUROPENTRAXIN-2”. 2026. Magna Neurologica 4 (2): 175-86. https://doi.org/10.20961/magnaneurologica.v4i2.3308.